Literature DB >> 17939933

Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management.

Mahnaz Fatahzadeh1, Robert A Schwartz.   

Abstract

Eight of the more than 80 known herpesviruses are human pathogens. Human herpes simplex virus (HSV) is a contagious infection with a large reservoir in the general population. It has a potential for significant complications in the immunocompromised host. In addition, psychological distress caused by the negative stigma associated with genital herpes and visible facial lesions in those experiencing frequent outbreaks renders it a challenging clinical dilemma. This article reviews the epidemiology, pathogenesis, and diagnostic features of HSV infections, providing the clinician with an up-to-date understanding of the available management strategies for mucocutaneous HSV-induced disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939933     DOI: 10.1016/j.jaad.2007.06.027

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  89 in total

1.  Regulation of herpes simplex virus type 1 thymidine kinase gene expression by thyroid hormone receptor in cultured neuronal cells.

Authors:  Shao-Chung V Hsia; Rajeswara C Pinnoji; Gautam R Bedadala; James M Hill; Jayavardhana R Palem
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

2.  Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association?

Authors:  Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

3.  Transmission heterogeneity and autoinoculation in a multisite infection model of HPV.

Authors:  Andrew F Brouwer; Rafael Meza; Marisa C Eisenberg
Journal:  Math Biosci       Date:  2015-10-27       Impact factor: 2.144

4.  Development and Validation of a Laboratory-Developed Multiplex Real-Time PCR Assay on the BD Max System for Detection of Herpes Simplex Virus and Varicella-Zoster Virus DNA in Various Clinical Specimens.

Authors:  Sylvie Pillet; Paul O Verhoeven; Amélie Epercieux; Thomas Bourlet; Bruno Pozzetto
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 5.  Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.

Authors:  Christopher M Hull; Myron J Levin; Stephen K Tyring; Spotswood L Spruance
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

Review 6.  Current management and recommendations for access to antiviral therapy of herpes labialis.

Authors:  Anthony Cunningham; Paul Griffiths; Peter Leone; Adrian Mindel; Rajul Patel; Lawrence Stanberry; Richard Whitley
Journal:  J Clin Virol       Date:  2011-09-01       Impact factor: 3.168

7.  The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease.

Authors:  Stacey Cerón; Brian J North; Sean A Taylor; David A Leib
Journal:  Virology       Date:  2019-01-06       Impact factor: 3.616

8.  Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.

Authors:  Ana M Chamoun-Emanuelli; Michael Bobardt; Bernard Moncla; Marie K Mankowski; Roger G Ptak; Philippe Gallay; Zhilei Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

9.  An extract of Stephania hernandifolia, an ethnomedicinal plant, inhibits herpes simplex virus 1 entry.

Authors:  Joy Mondal; Ananya Das Mahapatra; Keshab C Mandal; Debprasad Chattopadhyay
Journal:  Arch Virol       Date:  2021-05-26       Impact factor: 2.574

10.  Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice.

Authors:  Ling Jin; Dale Carpenter; Megan Moerdyk-Schauwecker; Adam L Vanarsdall; Nelson Osorio; Chinhui Hsiang; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.